Publications

Authors:

Schweiger, V; Martini, A; Bellamoli, Paola; Donadello, K; Schievano, C; Del Balzo, G; Sarzi-Puttini, P; Parolini, M; Polati, E

Title:

Ultramicronized palmitoylethanolamide (Um-PEA) as add-on treatment in fibromyalgia syndrome (FMS): Retrospective observational study on 407 patients

Year:

2019

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Referee:

No

Name of journal:

CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS

ISSN of journal:

1871-5273

N° Volume:

18

Number or Folder:

4

Page numbers:

326-333

Keyword:

Fibromyalgia Impact Questionnaire (FIQ); Symptoms Severity Score (SSS); Visual Analogue Scale (VAS); Widespread Pain Index (WPI); adverse events (AEs); fibromyalgia syndrome (FMS); mast-cells (MC).; ultramicronized palmitoylethanolamide (um-PEA)

Short description of contents:

fibromyalgia syndrome is a chronic multifaceted disease characterized by widespread pain, muscle stiffness, fatigue, unrefreshing sleep and cognitive disorders. To date, no medication has been shown to significantly improve pain, associated symptoms and Quality of Life in fibromyalgic patients.

Product ID:

109340

Handle IRIS:

11562/997490

Last Modified:

February 17, 2024

Bibliographic citation:

Schweiger, V; Martini, A; Bellamoli, Paola; Donadello, K; Schievano, C; Del Balzo, G; Sarzi-Puttini, P; Parolini, M; Polati, E, Ultramicronized palmitoylethanolamide (Um-PEA) as add-on treatment in fibromyalgia syndrome (FMS): Retrospective observational study on 407 patients «CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS» , vol. 18 , n. 4 , 2019 , pp. 326-333

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo